Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Laser zaps leakage: new hope for stress incontinence?

NCT ID NCT03996070

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed trial tested whether a special laser (Fotona Smooth Erbium YAG) can help women with stress urinary incontinence who haven't improved with exercises. Thirty women were randomly assigned to get either real laser treatments or a fake (sham) procedure, and neither they nor their doctors knew which they received. The main goal was to see if the laser reduced urine leakage more than the sham treatment at 6 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Erbium YAG laser
What this could lead to
If it works, this could offer a non-surgical, outpatient option to reduce urine leakage in women with stress incontinence.
What could go wrong
This is a small, early-stage trial with only 30 participants, so results may not apply widely. The sham control helps, but the laser might not work better than placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Jun 2022

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adult Female, 18 years of age or older 2. Clinical and UDS diagnosis of Stress Urinary Incontinence 3. SUI on 1-hour Pad weight test between 2g and 25g (SUI I: 2-10g, SUI II:11-25g) 4. No significant improvement in urinary incontinence from at least one previous conservative treatment, such as pelvic floor muscle training Exclusion Criteria: 1. Pre-existing bladder pathology including prior radiation treatment 2. Pregnancy 3. BMI\>35 4. Radical pelvic surgery or previous incontinence surgery 5. Urinary tract infection or other active infections of urinary tract or bladder 6. SUI on 1 hour pad weight test \>25g (SUI III: \>25g) 7. Any form of pelvic organ prolapse greater than stage 2, according to POP-Q 8. Diagnosis of urge incontinence 9. Diagnosis of collagen disorders eg.benign joint hypermobility / Elhers-Danlos / Marfans etc. 10. Incomplete bladder emptying 11. Vesicovaginal fistula 12. Faecal incontinence 13. Unwillingness or inability to complete follow-up schedule 14. Unwillingness or inability to give Informed Consent 15. Failure to comply with diary requirements during extended baseline period

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Female stress incontinence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Basingstoke & North Hampshire Hospital

    Basingstoke, Hampshire, RG24 9NA, United Kingdom